Organ-On-Chip Market

SKU: DMHCIT852 | Last Updated On: Oct 01 2022 | Available Formats

Organ-On-Chip Market Expected to reach a high CAGR of 31.2% by 2029: DataM Intelligence

Organ-On-Chip Market is segmented By Model (Liver-On-Chip Model, Lung-On-Chip Model, Heart-On-Chip Model, Kidney-On-Chip Model, Tumor Models, Custom & Multi-Organ-On-Chip Models, Other), By End Users (Pharmaceutical Companies, Research Organizations, Others)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029

[150 Pages Report] Organ-On-Chip Market is expected to grow at a high CAGR of 31.2% during the forecasting period (2022-2029).

Organ-On-Chip Market - Strategic Insights

Metrics

Details

Market CAGR

31.2%

Segments Covered

By Application, By End User, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Regions Analyzed

North America, Latin America, Europe, Middle East, Africa, Asia Pacific, and the Rest of the world.

Major Companies Covered

FzioMed, Inc., Amniox Medical, Inc., Human Regenerative Technologies, LLC, Amnio Technology, LLC, Derma Sciences, MiMedx Group, Inc, and among other major companies listed in the full report

To know more insights into the Market, Get Our Sample Brochure

  • Organ-on-chip is a multi-channel 3-D microfluid cell culture ship that stimulates activities, mechanisms, and physiological responses of entire organs.

  • These microdevices are translucent, they provide a window to watch the inner workings of human organs. This technology is being used to develop a whole pipeline of human organs on chips such as lung, gut, liver, heart, skin, bone marrow, pancreas, kidney, and even a system that mimics the blood-brain barrier.

  • These organ-on-chips help pharmaceutical companies in replacing animal cells, comparison studies between humans and animals, the study of the toxicity of drugs and cosmetics, developing vaccines and drugs to counter bioterrorism threats, etc.,

Geographical Analysis

  • The global organ-on-chip market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

  • North America dominates the global organ-on-chip due to a surge in the adoption of organs-on-chips over 2D and 3D cell cultures.

  • Furthermore, the rise in demand for organ-on-chip (OOCs) in drug screening, especially in the U.S., the rise in R&D initiatives, and the increase in the number of key players of OOCs in North America are expected to fuel the growth of the market in the coming years.

  • On April 11, 2017, FDA announced a multi-year research and development agreement with a company called Emulate Inc. to test the company’s “Organs-on-Chips” technology in laboratories at the agency’s Center for Food Safety and Applied Nutrition.

Market Drivers

  1. The provision of research funds grants is considered the key driver for the progress in the development of OOC devices and also positively impacts its market growth globally

  2. In 2017, NCATS awarded a research grant of 2 million to Emulate, Inc., to use its human Brain-Chip model and develop a fully automated research platform, to conduct experiments on the International Space Station.

  3. 2017, In 2017, NCATS and its NIH collaborators funded an estimated 15 million in the fiscal year 2017 to fund 13 awards for the ‘Tissue Chips for Disease Modeling and Efficacy Testing initiative.’

  4. The surge in demand for organ-on-chip devices in the healthcare industry is expected to boost the growth of the global organ-on-chip market. Real-time imaging, in-vitro analysis of biochemical, and genetic & metabolic activities of living cells in functional tissues are some of the applications of organ-on-chip devices in the industry.

Restraints

  • Major factors hindering the global organ-on-chip market are the high cost of devices because of the high manufacturing cost associated with complex manufacturing techniques.

 

Market Segmentation

  • The global organ-on-chip market is segmented by model and end users. Model type includes Liver-On-chip model, Lung-on-chip model, Heart-on-chip model, Kidney-on-chip model, Tumor models, Custom & Multi-organ-on-Chip models, and others, end users include pharmaceutical companies, research organizations, and others

  • The rise in mortality rate due to an increase in the incidence of liver diseases such as hepatitis B is expected to propel the demand for the liver-on-chip microfluidic model. Additionally, the surge in demand for liver-on-chip devices for drug screening is expected to fuel market growth.

Competitive Trends

  • Collaborative partnerships among the key players for research and development of advanced technology in the field of organ-on-chip and new product launches are driving the global organ-on-chip market.

  • In May 2018, Emulate, Inc. formed a collaborative partnership with AstraZeneca’s Innovative Medicines and Early Development (IMED) Biotech Unit to embed its Organs-on-Chips technology within the laboratories of the IMED Drug Safety organization.

  • In May 2018, CN Bio Innovations globally launched an organ-on-a-chip device that allows scientists to test potential drugs on living human organ models.

  • In October 2017, InSphero AG and Charles River Laboratories International, Inc. announced a partnership for the development of 3D InSight™ PDX Microtissues and expansion of in vitro oncology services.

  • In September 2017, AxoSim Technologies received a USD 1.7 million grant to expand its research aimed at fixing issues in pharmaceutical development.

  • Major market players in the Organ-on-chip market are CN Innovations Holdings Limited, Emulate, Inc., Axosim Technologies LLC, CN Bio Innovations, Kirkstall Limited, Insphero Ag, Mimetas B.V., Nortis Inc., Tissue Gmbh, Organovo Holdings, Inc., and Hesperos Inc.

Trending Topics

Artificial Disc Replacement Market

Artificial-Heart Lung Machine Market

Heating Pad Market

FAQ

What is the Organ-On-Chip Market growth?

The market is growing at a CAGR of 31.2%.

What is Organ-On-Chip Market size in 2021

The Organ-On-Chip Market size was valued at USD YY million in 2021.

Who are the key players in Organ-On-Chip Market?

Emulate, Inc., Axosim Technologies LLC, CN Bio Innovations, Kirkstall Limited, Insphero Ag, Mimetas B.V.

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest